INFLIXIMAB-AXXQ for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5 adverse event reports in the FDA FAERS database where INFLIXIMAB-AXXQ was used for Psoriasis.
Most Reported Side Effects for INFLIXIMAB-AXXQ
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product storage error | 144 | 19.9% | 0 | 1 |
| Off label use | 137 | 19.0% | 9 | 41 |
| Circumstance or information capable of leading to medication error | 99 | 13.7% | 0 | 1 |
| Drug ineffective | 57 | 7.9% | 2 | 5 |
| Infusion related reaction | 51 | 7.1% | 4 | 10 |
| Dyspnoea | 45 | 6.2% | 3 | 10 |
| Rash | 43 | 6.0% | 1 | 3 |
| Intercepted product administration error | 41 | 5.7% | 0 | 0 |
| Fatigue | 38 | 5.3% | 2 | 5 |
| Pain | 38 | 5.3% | 3 | 6 |
| Headache | 35 | 4.8% | 3 | 6 |
| Arthralgia | 34 | 4.7% | 1 | 5 |
| Pruritus | 32 | 4.4% | 2 | 3 |
| Diarrhoea | 28 | 3.9% | 0 | 7 |
| Crohn's disease | 24 | 3.3% | 2 | 11 |
Other Indications for INFLIXIMAB-AXXQ
Product used for unknown indication (376)
Crohn's disease (141)
Rheumatoid arthritis (58)
Colitis ulcerative (50)
Ankylosing spondylitis (21)
Psoriatic arthropathy (12)
Hidradenitis (10)
Colitis (9)
Sarcoidosis (7)
Exposure during pregnancy (6)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)